Randomized study of low-dose versus standard-dose chemoradiotherapy for unresectable esophageal squamous cell carcinoma (JCOG0303)

Cancer Science

Volumn 106, Issue 4, 2015, Pages 407-412

  Shinoda, Masayuki ^a   Ando, Nobutoshi ^b   Kato, Ken ^c   Ishikura, Satoshi ^d   Kato, Hoichi ^c   Tsubosa, Yasuhiro ^e   Minashi, Keiko ^f   Okabe, Hiroshi ^g   Kimura, Yusuke ^h   Kawano, Tatsuyuki ⁱ   Kosugi, Shin Ichi ^j   Toh, Yasushi ^k   Nakamura, Kenichi ^l   Fukuda, Haruhiko ^l  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b TOKYO DENTAL COLLEGE   (Japan)

^c NATIONAL CANCER CENTER HOSPITAL   (Japan)

^d Koshigaya Municipal Hospital   (Japan)

^e SHIZUOKA CANCER CENTER   (Japan)

^f NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^g KYOTO UNIVERSITY HOSPITAL   (Japan)

^h IWATE MEDICAL UNIVERSITY   (Japan)

ⁱ TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^j NIIGATA UNIVERSITY   (Japan)

^k NATIONAL KYUSHU CANCER CENTER   (Japan)

^l NATIONAL CANCER CENTER   (Japan)

more..

Author keywords

Chemoradiotherapy; Esophageal squamous cell carcinoma; Randomized trial; Survival; Toxicity

Indexed keywords

CISPLATIN; FLUOROURACIL; ANTINEOPLASTIC AGENT;

ADJUVANT CHEMORADIOTHERAPY; ADULT; AGED; ANEMIA; ANOREXIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONTINUOUS INFUSION; CONTROLLED STUDY; DYSPHAGIA; DYSPNEA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGITIS; FEMALE; FISTULA; HUMAN; HUMAN TISSUE; HYPONATREMIA; LEUKOPENIA; LOW DRUG DOSE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEGAVOLTAGE RADIOTHERAPY; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; ODYNOPHAGIA; OVERALL SURVIVAL; PERICARDITIS; PNEUMONIA; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RANDOMIZED CONTROLLED TRIAL; STANDARD; THROMBOCYTOPENIA; TREATMENT DURATION; VOMITING; ADVERSE EFFECTS; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; CLINICAL TRIAL; DOSE RESPONSE; ESOPHAGEAL NEOPLASMS; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PHASE 2 CLINICAL TRIAL; PROCEDURES; RADIATION RESPONSE; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; CISPLATIN; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; ESOPHAGEAL NEOPLASMS; FEMALE; FLUOROURACIL; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 84928051802     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/cas.12622     Document Type: Article

References (30)

1. Comprehensive Registry of Esophageal Cancer in Japan (1998, 1999) & Long-Term Results of Esophagectomy in Japan (1988-1997), 3rd edn. Tokyo: The Japanese Society for Esophageal Diseases, 2002.
2. Matsubara T, Ueda M, Kokubo N et al. Role of esophagectomy in treatment of esophageal carcinoma with clinical evidence of adjacent organ invasion. World J Surg 2001; 25: 279-84.
3. Ikeda K, Ishida K, Sato N et al. Chemoradiotherapy followed by surgery for thoracic esophageal cancer potentially or actually involving adjacent organs. Dis Esophagus 2001; 14: 197-201.
4. Ishida K, Ando N, Yamamoto S et al. Phase II study of cisplatin and 5- fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group(JEOG)/Japan Clinical Oncology Group Trial(JCOG 9516). Jpn J Clin Oncol 2004; 34: 615-9.
5. Fujita H, Sueyoshi S, Tanaka T et al. Esophagectomy: is it necessary after chemoradiotherapy for a locally advanced T4 esophageal cancer? Prospective nonrandomized trial comparing chemoradiotherapy with surgery versus without surgery. World J Surg 2005; 29: 25-30.
6. Ohtsu A, Boku N, Muro K et al. Definitive chemoradiotherapy for T4 and /or M1 lymph node squamous cell carcinoma of the esophagus. J Clin Oncol 1999; 17: 2915-21.
7. Scanlon KJ, Newman EM, Lu Y et al. Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells. Proc Natl Acad Sci USA 1986; 83: 8923-5.
8. Milano G, Troger V, Courdi A et al. Pharmacokinetics of cisplatin given at a daily low dose as a radiosensitiser. Cancer Chemother Pharmacol 1990; 27: 55-9.
9. Byfield JE. Combined modality infusing chemotherapy with radiation. In: Lokich JJ, ed. Cancer Chemothrapy by Infusion, 2nd edn. Chicago, IL: Percepta Press, 1990; 521-51.
10. UICC, eds. TNM Classification of Malignant Tumours, 5th edn. Berlin: Springer Verlag, 1997.
11. Picus D, Balfe DM, Kochler RE et al. Computed tomography in the staging of esophageal carcinoma. Radiology 1983; 146: 433-8.
12. Sanuki N, Ishikura S, Shinoda M et al. Radiotherapy quality assurance review for a multi-center randomized trial of locally advanced esophageal cancer: the Japan Clinical Oncology Group (JCOG) trial 0303. Int J Clin Oncol 2012; 17: 105-11.
13. Ishikura S, Ohtsu A, Shirao K et al. A phase I/II study of nedaplatin and 5-fluorouracil with concurrent radiotherapy in patients with T4 esophageal cancer: Japan Clinical Oncology Group trial (JCOG9908). Esophagus 2005; 2: 133-7.
14. Herskovic A, Martz K, Al-Sarraf M, et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992; 326: 1593-8.
15. Al-Sarraf M, Martz K, Herskovic A et al. Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with cancer of the esophagus. J Clin Oncol 1997; 15: 277-84.
16. Van Harskamp G, Boven E, Vermorken JB et al. Phase II trial of combined radiotherapy and daily low-dose cisplatin for inoperable, locally advanced non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 1987; 13: 1735-8.
17. Schaake-Koning C, Maat B, van Houtte P et al. Radiotherapy combined with low-dose cis-diamimine dichloroplatinum (II) (CDDP) in inoperable nonmetastatic non- small cell lung cancer (NSCLC): a randomized three arm phase II study of the EORTC lung cancer and radiotherapy cooperative groups. Int J Radiation Oncology Biol Phys 1990; 19: 967-72.
18. Ellerbroek NA, Fossella FV, Rich TA et al. Low-dose continuous infusion cisplatin combined with external beam irradiation for advanced colorectal adenocarcinoma and unresectable non-small cell lung carcinoma. Int J Radiation Oncology Biol Phys 1991; 20: 351-5.
19. Hazuka MB, Crowley JJ, Bunn PA Jr et al. Daily low-dose cisplatin plus concurrent high-dose thoracic irradiation in locally advanced unresectable non-small cell lung: Results of a phase II Southwest Oncology Group Study. J Clin Oncol 1994; 12: 1814-20.
20. Choi KN, Rotman M, Aziz H et al. Locally advanced paranasal sinus and nasopharynx tumors treated with hyperfractionated radiation and concomitant infusion cisplatin. Cancer 1991; 67: 2748-52.
21. Jeremic B, Shibamoto Y, Milicic B et al. Hyperfractionated radiation therapy with or without concurrent low-dose cisplatin in locally advanced squamous cell carcinoma of the head and neck: A prospective randomized trial. J Clin Oncol 2000; 18: 1458-64.
22. Sasaki K, Inakoshi H, Sueyama H et al. Concurrent radiotherapy and chemotherapy with protracted continuous infusion of 5-fluorouracil in inoperable esophageal squamous cell carcinoma. Int J Radiation Oncology Biol Phys 1995; 31: 921-7.
23. Raoul JL, Prise EL, Meunier B et al. Neoadjuvant chemotherapy and hyperfractionated radiotherapy with concurrent low-dose chemotherapy for squamous cell esophageal carcinoma. Int J Radiation Oncology Biol Phys 1998; 42: 29-34.
24. Sasamoto R, Sakai K, Inakoshi H et al. Long-term results of chemoradiotherapy for locally advanced esophageal cancer, using low-dose 5-fluorouracil and cis-diammine-dichloroplatinum (CDDP). Int J Clin Oncol 2007; 12: 25-30.
25. Takagawa R, Kunisaki C, Makino H et al. Efficacy of chemoradiothrapy with low-dose cisplatin and continuous infusion of 5-fluorouracil for unresectable squamous cell carcinoma of the esophagus. Dis Esophagus 2009; 22: 482-9.
26. Kaneko K, Inakoshi H, Konishi K et al. Definitive chemoradiotherapy for patients with malignant stricture due to T3 or T4 squamous cell carcinoma of the esophagus. Br J Cancer 2003; 88: 18-24.
27. Nishimura Y, Suzuki M, Nakamatsu K et al. Prospective trial of concurrent chemoradiotherapy with protracted infusion of 5-fluorouracil and cisplatin for T4 esophageal cancer with or without fistula. Int J Radiation Oncology Biol Phys 2002; 53: 134-9.
28. Roussel A, Cheze S, Jacob JF et al. Radiation therapy in esophageal carcinoma with broncho-tracheal involvement (BTI): The Center Francois Baclesse (CFB) experience. Proc Am Soc Clin Oncol 1995; 14: 191a. abstr438.
29. Sai H, Mitsumori M, Yamauchi C et al. Concurrent chemoraditherapy for esophageal cancer: comparison between intermittent standard dose cisplatin with 5-fluorouracil and daily low dose cisplatin with continuous infusion of 5-fluorouracil. Int J Clin Oncol 2004; 9: 149-53.
30. Nishimura Y, Hiraoka M, Koike R et al. Long-term follow-up of a randomized Phase II study of cisplatin/5-FU concurrent chemoradiotherapy for esophageal cancer (KROSG0101/JROSG021). Jpn J Clin Oncol 2012; 42: 807-12.